Chimeric Antigen Receptor T Cell Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
ACET | F | Adicet Bio, Inc. | -7.18 | |
GDTC | F | CytoMed Therapeutics Limited | -4.55 | |
CRBU | F | Caribou Biosciences, Inc. | -1.33 | |
TSVT | F | 2seventy bio, Inc. | -0.82 | |
CARM | F | Carisma Therapeutics, Inc. | 0.00 | |
JANX | B | Janux Therapeutics, Inc. | 0.62 | |
NKTX | D | Nkarta, Inc. | 0.73 | |
NTLA | F | Intellia Therapeutics, Inc. | 3.70 | |
PSTX | D | Poseida Therapeutics, Inc. | 3.90 | |
SNTI | F | Senti Biosciences, Inc. | 4.05 |
Related Industries: Biotechnology
Related Stock Lists:
Medicine
Immune System
Biopharmaceutical
Biotechnology
Cancer
Chimeric Antigen Receptor
Clinical Medicine
Solid Tumors
Antigen
Biology
Cancer Immunotherapy
Cancer Treatment
Cell Therapy
Life Sciences
Natural Killer Cell
Breakthrough Therapy
CD19
Disease
Emerging Technologies
Gene Therapy
Related ETFs - A few ETFs which own one or more of the above listed Chimeric Antigen Receptor T Cell stocks.
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
CNCR | D | Loncar Cancer Immunotherapy ETF | 5.59 | |
GNOM | F | Global X Genomics & Biotechnology ETF | 4.54 | |
ARKG | F | ARK Genomic Revolution Multi-Sector ETF | 3.9 | |
WDNA | D | WisdomTree BioRevolution Fund | 2.56 | |
ARKK | D | ARK Innovation ETF | 2.48 |
Compare ETFs
Related Industries:
Biotechnology
Related Stock Lists:
Medicine
Immune System
Biopharmaceutical
Biotechnology
Cancer
Chimeric Antigen Receptor
Clinical Medicine
Solid Tumors
Antigen
Biology
Cancer Immunotherapy
Cancer Treatment
Cell Therapy
Life Sciences
Natural Killer Cell
Breakthrough Therapy
CD19
Disease
Emerging Technologies
Gene Therapy
- Chimeric Antigen Receptor T Cell
Chimeric Antigen Receptor T Cell (CAR-T) is a type of immunotherapy that uses a patient’s own T cells to fight cancer. The T cells are genetically modified to express a special receptor, called a chimeric antigen receptor (CAR), which is designed to recognize and bind to a specific protein found on the surface of cancer cells. Once the CAR-T cells bind to the cancer cells, they can kill them. CAR-T therapy has been used to treat certain types of blood cancers, such as leukemia and lymphoma, and is being studied for other types of cancer.
Popular Now
Recent Comments
- TraderMike on IZM
- SuccessfulGerbil321 on IZM
- TraderMike on IZM
- TraderMike on Today's Outage
- Crunching_The_Market on Today's Outage
From the Blog
Featured Articles